Follow the Zim Laboratories share price and the full insider trade history of the company, a listed issuer based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Market capitalisation: €6.2bn. The latest transaction was disclosed on 29 July 2026 (Acquisition). Among the most active insiders: Anwar Daud. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Zim Laboratories is a company focused on the research and development of pharmaceutical products. It is listed on the Bombay Stock Exchange under the symbol XBOM.